axon & dorsal cluster neuron, with Scer\GAL4ato.3.6
eye, with Scer\GAL4GMR.PF
eye, with Scer\GAL4GMR.PU
ventral adult lateral neuron & axon, with Scer\GAL4P2.4.Pdf
wing | ectopic, with Scer\GAL4rn-GAL4-5
The expression of Traf6UAS.cSa under the control of Scer\GAL4sim.PS suppresses mitosis in the ventral midline of stage 13 embryos.
40-hour- (but not 24-hour-) expression of hepCA.UAS under the control of Scer\GAL4rn-GAL4-5 (with tub-Gal80[ts] restricting expression to third instar larvae) leads to occasional ectopic wings compared to controls.
Expression of hepCA.UAS under the control of Scer\GAL4GMR.PF results in a small eye phenotype.
The expression of hepCA.Scer\UAS under the control of Scer\GAL4GMR.PU leads to a severe increase in apoptosis in the third instar larval eye disc morphogenetic furrow and to small eye and rough eye phenotypes in adults, as compared to controls; expression under the control of Scer\GAL4ptc-559.1 leads to a severe increase in apoptosis around the anterior-posterior compartment boundary of the third instar larval wing disc and to a highly penetrant anterior crossvein loss in the adult wing, as compared to controls.
Pulse (16 hr) expression of hepCA.Scer\UAS under the control of Scer\GAL4pnr-MD237, using tub-Gal80ts to limit the time of expression to third larval instar results in formation of a giant syncytium comprising the whole of Scer\GAL4pnr-MD237 expressing patches in the larval epidermis.
Expression of hepCA.Scer\UAS under the control of Scer\GAL4GMR.PF induces cell death in the eye disc and generates a small-eye phenotype.
Expression of hepCA.Scer\UAS under the control of Scer\GAL4wor.PA induces neuroblast loss in larval brains.
Expression of hepCA.Scer\UAS under the control of Scer\GAL4sev.PU triggers extensive cell death in larval eye discs and produces rough eyes with reduced sizes.
Expression of constitutively active hepCA.Scer\UASunder the control of either Scer\GAL4elav.Switch.PO or Scer\GAL4αTub84B.Switch.PK results in a robust weakening of the regenerative response after axonal injury.
Expression of hepCA.Scer\UAS under the control of Scer\GAL4elav.Switch.PO results in a marked increase in the size of pigmented scar after injury.
Expression of the constitutively active hepCA.Scer\UAS transgene, under the control of Scer\GAL4pnr-MD237, generates a small scutellum phenotype.
Expression of hepCA.Scer\UAS under the control of Scer\GAL4ptc-559.1 results in loss of the anterior cross vein.
Expression of hepCA.Scer\UAS under the control of Scer\GAL4GMR.PF results in reduced eclosion rates; 67% of flies eclose at 18[o]C and 0.75% at 24[o]C.
Expression of hepCA.Scer\UAS under the control of Scer\GAL4GMR.PF results in a reduction in eye size; eye size is 17% of control in females and 18% in males.
Follicle cells expressing hepCA.Scer\UAS under the control of Scer\GAL4GR1 in unstarved flies display a hyper-engulfment phenotype in which they invade and surround apparently healthy nurse cells, culminating in the follicle cells engulfing intact nurse cells and inducing their death.
Expression of hepCA.Scer\UAS in the developing eye under the control of Scer\GAL4GMR.PF induces JNK-mediated cell death and produces a small eye phenotype.
The eye-degeneration phenotype caused by expression of hepCA.Scer\UAS under the control of Scer\GAL4hs.2sev is not mitigated by feeding flies with linoleic acid and linolenic acid.
Expression of hepCA.Scer\UAS driven by Scer\GAL4sev.PU results in a rough eye phenotype. Large numbers of dead cells are detected in the eye imaginal disc of Scer\GAL4sev.PU>hepCA.Scer\UAS third instar larvae.
Expression of hepCA.Scer\UAS under the control of Scer\GAL4GMR.PF produces a small eye phenotype.
Expression of hepCA.Scer\UAS under the control of Scer\GAL4vg.PU results in lethality at 25oC, while at 18oC the flies are viable and have wing defects. The wing defects seen at 18oC include missing posterior wing-vein material, notches in the wing margins and held-out wings.
Weak expression of hepCA.Scer\UAS in the posterior region of the wing using the Scer\GAL4CY2 driver leads to a partial loss of the fifth longitudinal vein (L5).
Overexpression of hepCA.Scer\UAS in eye clones, under the control of Scer\GAL4GMR.PF results in a severe eye phenotype with apparently massive levels of apoptosis.
Expression of hepCA.Scer\UAS, under the control of Scer\GAL4ato.3.6, results in all dorsal cluster neurons crossing to the medulla, while in wild-type brains, the majority of these axons retract during pupal development and branch within the lobula.
Expression of hepCA.Scer\UAS under the control of Scer\GAL4GMR.PF causes a reduction in eye size.
Expression of hepCA.Scer\UAS, under the control of Scer\GAL4P2.4.Pdf, induces axonal overextension of the sLNv without increased arborization.
Expression of hepCA.Scer\UAS, under the control of Scer\GAL4e22c, leads to embryonic lethality before dorsal closure.
When expression is driven by Scer\GAL4He.PZ, hemocyte proliferation is unaffected, lamellocyte numbers are increased and crystal cells are unaffected. Melanotic masses form. Similar, though milder, effects are seen when expression is driven by Scer\GAL4Hml.PG.
Scer\GAL4rn-GAL4-5, hepCA.UAS has visible | adult stage phenotype, non-enhanceable by CtBP[+]/CtBP87De-10
Scer\GAL4GMR.PU, hepCA.UAS has abnormal size | adult stage phenotype, suppressible | partially by Glyatc02982/Glyat[+]
Scer\GAL4GMR.PU, hepCA.UAS has visible | adult stage phenotype, suppressible | partially by Glyatc02982/Glyat[+]
Scer\GAL4GMR.PU, hepCA.UAS has abnormal size | adult stage phenotype, suppressible | partially by GlyatTH00482, Scer\GAL4GMR.PU
Scer\GAL4GMR.PU, hepCA.UAS has visible | adult stage phenotype, suppressible | partially by GlyatTH00482, Scer\GAL4GMR.PU
Scer\GAL4GMR.PU, hepCA.UAS has abnormal size | adult stage phenotype, suppressible | partially by bskNIG.5680R/Scer\GAL4GMR.PU
Scer\GAL4GMR.PU, hepCA.UAS has visible | adult stage phenotype, suppressible | partially by bskNIG.5680R/Scer\GAL4GMR.PU
Scer\GAL4GMR.PU, hepCA.UAS has increased cell death | third instar larval stage phenotype, suppressible | partially by Glyatc02982/Glyat[+]
Scer\GAL4GMR.PU, hepCA.UAS has increased cell death | third instar larval stage phenotype, suppressible | partially by GlyatTH00482, Scer\GAL4GMR.PU
Scer\GAL4GMR.PU, hepCA.UAS has increased cell death | third instar larval stage phenotype, suppressible | partially by bskNIG.5680R/Scer\GAL4GMR.PU
Scer\GAL4ptc-559.1, hepCA.UAS has increased cell death | third instar larval stage phenotype, suppressible | partially by Glyatc02982/Glyat[+]
Scer\GAL4ptc-559.1, hepCA.UAS has increased cell death | third instar larval stage phenotype, suppressible | partially by GlyatTH00482, Scer\GAL4ptc-559.1
Scer\GAL4ptc-559.1, hepCA.UAS has increased cell death | third instar larval stage phenotype, suppressible | partially by Scer\GAL4ptc-559.1/bskNIG.5680R
Scer\GAL4GMR.PF, hepCA.UAS has abnormal size phenotype, suppressible by armNIG.11579R/Scer\GAL4GMR.PF
Scer\GAL4GMR.PF, hepCA.UAS has visible phenotype, suppressible by armNIG.11579R/Scer\GAL4GMR.PF
Scer\GAL4GMR.PF, hepCA.UAS has abnormal size phenotype, suppressible by panVDRC.cUa/Scer\GAL4GMR.PF
Scer\GAL4GMR.PF, hepCA.UAS has visible phenotype, suppressible by panVDRC.cUa/Scer\GAL4GMR.PF
Scer\GAL4GMR.PF, hepCA.UAS has abnormal size phenotype, suppressible by sggEP1576/Scer\GAL4GMR.PF
Scer\GAL4GMR.PF, hepCA.UAS has visible phenotype, suppressible by sggEP1576/Scer\GAL4GMR.PF
Scer\GAL4GMR.PF, hepCA.UAS has abnormal size phenotype, suppressible by AxnUAS.GFP, Scer\GAL4GMR.PF
Scer\GAL4GMR.PF, hepCA.UAS has visible phenotype, suppressible by AxnUAS.GFP, Scer\GAL4GMR.PF
Scer\GAL4GMR.PF, hepCA.UAS has abnormal size phenotype, suppressible by bsk1/bsk[+]
Scer\GAL4GMR.PF, hepCA.UAS has visible phenotype, suppressible by bsk1/bsk[+]
Scer\GAL4GMR.PF, hepCA.UAS has abnormal size phenotype, suppressible by wg[+]/wgl-8
Scer\GAL4GMR.PF, hepCA.UAS has visible phenotype, suppressible by wg[+]/wgl-8
Scer\GAL4GMR.PF, hepCA.UAS has abnormal size phenotype, suppressible by arm2/arm[+]
Scer\GAL4GMR.PF, hepCA.UAS has visible phenotype, suppressible by arm2/arm[+]
Scer\GAL4GMR.PF, hepCA.UAS has abnormal size phenotype, suppressible by wgNIG.4889R/Scer\GAL4GMR.PF
Scer\GAL4GMR.PF, hepCA.UAS has visible phenotype, suppressible by wgNIG.4889R/Scer\GAL4GMR.PF
Scer\GAL4GMR.PF, hepCA.UAS has lethal | heat sensitive phenotype, suppressible by HAdV-C\E4orf4UAS.cPa, Scer\GAL4GMR.PF
Scer\GAL4GMR.PF, hepCA.UAS has visible | adult stage phenotype, suppressible by HAdV-C\E4orf4UAS.cPa, Scer\GAL4GMR.PF
Scer\GAL4GMR.PF, hepCA.UAS has abnormal size | adult stage phenotype, suppressible by HAdV-C\E4orf4UAS.cPa, Scer\GAL4GMR.PF
Scer\GAL4sev.PU, hepCA.UAS has visible phenotype, suppressible by Scer\GAL4sev.PU/parkUAS.Tag:MYC
Scer\GAL4sev.PU, hepCA.UAS has increased cell death | third instar larval stage phenotype, suppressible by Scer\GAL4sev.PU/parkUAS.Tag:MYC
Scer\GAL4GMR.PF, hepCA.UAS has abnormal size | adult stage phenotype, suppressible by Mkk4UAS.cGa, Scer\GAL4GMR.PF
Scer\GAL4GMR.PF, hepCA.UAS has visible | adult stage phenotype, suppressible by Mkk4UAS.cGa, Scer\GAL4GMR.PF
Scer\GAL4GMR.PF, hepCA.UAS has abnormal size | adult stage phenotype, suppressible by Mkk4Mut.UAS, Scer\GAL4GMR.PF
Scer\GAL4GMR.PF, hepCA.UAS has visible | adult stage phenotype, suppressible by Mkk4Mut.UAS, Scer\GAL4GMR.PF
Scer\GAL4GMR.PF, hepCA.UAS has visible phenotype, suppressible by bskG258/bsk[+]
Scer\GAL4rn-GAL4-5, hepCA.UAS has visible | adult stage phenotype, non-suppressible by CtBP[+]/CtBP87De-10
Scer\GAL4GMR.PF, hepCA.UAS has abnormal size | adult stage phenotype, non-suppressible by HUWE1EY01689, Scer\GAL4GMR.PF
Scer\GAL4GMR.PF, hepCA.UAS has visible | adult stage phenotype, non-suppressible by HUWE1EY01689, Scer\GAL4GMR.PF
Scer\GAL4pnr-MD237, hepCA.UAS has increased cell size | third instar larval stage phenotype, non-suppressible by Cdk1GL00262, Scer\GAL4pnr-MD237
Scer\GAL4pnr-MD237, hepCA.UAS has abnormal cell shape | third instar larval stage phenotype, non-suppressible by aurBGL00202/Scer\GAL4pnr-MD237
Scer\GAL4pnr-MD237, hepCA.UAS has increased cell size | third instar larval stage phenotype, non-suppressible by aurBGL00202/Scer\GAL4pnr-MD237
Scer\GAL4pnr-MD237, hepCA.UAS has abnormal cell shape | third instar larval stage phenotype, non-suppressible by DarkGD12048, Scer\GAL4pnr-MD237
Scer\GAL4pnr-MD237, hepCA.UAS has increased cell size | third instar larval stage phenotype, non-suppressible by DarkGD12048, Scer\GAL4pnr-MD237
Scer\GAL4pnr-MD237, hepCA.UAS has abnormal cell shape | third instar larval stage phenotype, non-suppressible by BacA\p35UAS.cUa, Scer\GAL4pnr-MD237
Scer\GAL4pnr-MD237, hepCA.UAS has increased cell size | third instar larval stage phenotype, non-suppressible by BacA\p35UAS.cUa, Scer\GAL4pnr-MD237
Scer\GAL4pnr-MD237, hepCA.UAS has abnormal cell shape | third instar larval stage phenotype, non-suppressible by Cdk1GL00262, Scer\GAL4pnr-MD237
Scer\GAL4sev.PU, hepCA.UAS has visible phenotype, non-suppressible by ben1
Scer\GAL4GMR.PF, hepCA.UAS has neoplasia phenotype, non-suppressible by Uev1AGD6650/Scer\GAL4GMR.PF
Scer\GAL4GMR.PF, hepCA.UAS has partially lethal - majority live | temperature conditional phenotype, non-suppressible by HAdV-C\E4orf4UAS.cPa, Scer\GAL4GMR.PF
Scer\GAL4GMR.PF, hepCA.UAS has abnormal size | adult stage phenotype, non-suppressible by Mkk4G673/Mkk4G587
Scer\GAL4GMR.PF, hepCA.UAS has visible | adult stage phenotype, non-suppressible by Mkk4G673/Mkk4G587
Scer\GAL4GMR.PF, hepCA.UAS has abnormal size | adult stage phenotype, non-suppressible by Mkk4Asp.UAS, Scer\GAL4GMR.PF
Scer\GAL4GMR.PF, hepCA.UAS has visible | adult stage phenotype, non-suppressible by Mkk4Asp.UAS, Scer\GAL4GMR.PF
Scer\GAL4GMR.PF, hepCA.UAS has visible phenotype, non-suppressible by Tab2[+]/Tab2G71
Scer\GAL4GMR.PF, hepCA.UAS has visible phenotype, non-suppressible by Tak1unspecified
Scer\GAL4P2.4.Pdf, hepCA.UAS has abnormal neuroanatomy phenotype, non-suppressible by Appld
Scer\GAL4sim.PS/hepCA.UAS is a suppressor of increased occurrence of cell division | embryonic stage 13 phenotype of Scer\GAL4sim.PS, dlUAS.cHa
hepCA.UAS/Scer\GAL4GR1 is a suppressor of abnormal cell death | nutrition conditional phenotype of drprΔ5
hepCA.UAS, Scer\GAL4Act5C.PI is a suppressor of neoplasia | somatic clone phenotype of Ras85DV12.UAS, Scer\GAL4Act5C.PI, shgk03401
Scer\GAL4vg.PU, hepCA.UAS has wing phenotype, enhanceable by flw1
Scer\GAL4rn-GAL4-5, hepCA.UAS has wing | ectopic phenotype, non-enhanceable by CtBP[+]/CtBP87De-10
Scer\GAL4GMR.PU, hepCA.UAS has eye phenotype, suppressible | partially by Glyatc02982/Glyat[+]
Scer\GAL4GMR.PU, hepCA.UAS has eye phenotype, suppressible | partially by GlyatTH00482, Scer\GAL4GMR.PU
Scer\GAL4GMR.PU, hepCA.UAS has eye phenotype, suppressible | partially by bskNIG.5680R/Scer\GAL4GMR.PU
Scer\GAL4GMR.PU, hepCA.UAS has eye disc morphogenetic furrow | third instar larval stage phenotype, suppressible | partially by Glyatc02982/Glyat[+]
Scer\GAL4GMR.PU, hepCA.UAS has eye disc morphogenetic furrow | third instar larval stage phenotype, suppressible | partially by GlyatTH00482, Scer\GAL4GMR.PU
Scer\GAL4GMR.PU, hepCA.UAS has eye disc morphogenetic furrow | third instar larval stage phenotype, suppressible | partially by bskNIG.5680R/Scer\GAL4GMR.PU
Scer\GAL4ptc-559.1, hepCA.UAS has anterior-posterior compartment boundary of the wing disc | third instar larval stage phenotype, suppressible | partially by Glyatc02982/Glyat[+]
Scer\GAL4ptc-559.1, hepCA.UAS has anterior-posterior compartment boundary of the wing disc | third instar larval stage phenotype, suppressible | partially by GlyatTH00482, Scer\GAL4ptc-559.1
Scer\GAL4ptc-559.1, hepCA.UAS has anterior-posterior compartment boundary of the wing disc | third instar larval stage phenotype, suppressible | partially by Scer\GAL4ptc-559.1/bskNIG.5680R
Scer\GAL4ptc-559.1, hepCA.UAS has anterior crossvein | third instar larval stage phenotype, suppressible | partially by Glyatc02982/Glyat[+]
Scer\GAL4ptc-559.1, hepCA.UAS has anterior crossvein | third instar larval stage phenotype, suppressible | partially by GlyatTH00482, Scer\GAL4ptc-559.1
Scer\GAL4ptc-559.1, hepCA.UAS has anterior crossvein | third instar larval stage phenotype, suppressible | partially by Scer\GAL4ptc-559.1/bskNIG.5680R
Scer\GAL4GMR.PF, hepCA.UAS has eye phenotype, suppressible by wg[+]/wgl-8
Scer\GAL4GMR.PF, hepCA.UAS has eye phenotype, suppressible by arm2/arm[+]
Scer\GAL4GMR.PF, hepCA.UAS has eye phenotype, suppressible by wgNIG.4889R/Scer\GAL4GMR.PF
Scer\GAL4GMR.PF, hepCA.UAS has eye phenotype, suppressible by armNIG.11579R/Scer\GAL4GMR.PF
Scer\GAL4GMR.PF, hepCA.UAS has eye phenotype, suppressible by panVDRC.cUa/Scer\GAL4GMR.PF
Scer\GAL4GMR.PF, hepCA.UAS has eye phenotype, suppressible by sggEP1576/Scer\GAL4GMR.PF
Scer\GAL4GMR.PF, hepCA.UAS has eye phenotype, suppressible by AxnUAS.GFP, Scer\GAL4GMR.PF
Scer\GAL4GMR.PF, hepCA.UAS has eye phenotype, suppressible by bsk1/bsk[+]
Scer\GAL4GMR.PF, hepCA.UAS has eye phenotype, suppressible by HAdV-C\E4orf4UAS.cPa, Scer\GAL4GMR.PF
Scer\GAL4sev.PU, hepCA.UAS has eye phenotype, suppressible by Scer\GAL4sev.PU/parkUAS.Tag:MYC
Scer\GAL4sev.PU, hepCA.UAS has eye disc | third instar larval stage phenotype, suppressible by Scer\GAL4sev.PU/parkUAS.Tag:MYC
Scer\GAL4GMR.PF, hepCA.UAS has eye phenotype, suppressible by Mkk4UAS.cGa, Scer\GAL4GMR.PF
Scer\GAL4GMR.PF, hepCA.UAS has eye phenotype, suppressible by Mkk4Mut.UAS, Scer\GAL4GMR.PF
hepCA.UAS has wing vein L5 phenotype, suppressible by Scer\GAL4CY2/Bant\lefUAS.cGa
Scer\GAL4GMR.PF, hepCA.UAS has eye phenotype, suppressible by bskG258/bsk[+]
Scer\GAL4rn-GAL4-5, hepCA.UAS has wing | ectopic phenotype, non-suppressible by CtBP[+]/CtBP87De-10
Scer\GAL4GMR.PF, hepCA.UAS has eye phenotype, non-suppressible by HUWE1EY01689, Scer\GAL4GMR.PF
Scer\GAL4pnr-MD237, hepCA.UAS has embryonic/larval epidermis | third instar larval stage phenotype, non-suppressible by Cdk1GL00262, Scer\GAL4pnr-MD237
Scer\GAL4pnr-MD237, hepCA.UAS has embryonic/larval epidermis | third instar larval stage phenotype, non-suppressible by aurBGL00202/Scer\GAL4pnr-MD237
Scer\GAL4pnr-MD237, hepCA.UAS has embryonic/larval epidermis | third instar larval stage phenotype, non-suppressible by DarkGD12048, Scer\GAL4pnr-MD237
Scer\GAL4pnr-MD237, hepCA.UAS has embryonic/larval epidermis | third instar larval stage phenotype, non-suppressible by BacA\p35UAS.cUa, Scer\GAL4pnr-MD237
Scer\GAL4sev.PU, hepCA.UAS has eye phenotype, non-suppressible by ben1
Scer\GAL4GMR.PF, hepCA.UAS has eye phenotype, non-suppressible by Uev1AGD6650/Scer\GAL4GMR.PF
Scer\GAL4ptc-559.1, hepCA.UAS has anterior crossvein phenotype, non-suppressible by Scer\GAL4pnr-MD237/Uev1AGD6650
Scer\GAL4GMR.PF, hepCA.UAS has eye phenotype, non-suppressible by Mkk4G673/Mkk4G587
Scer\GAL4GMR.PF, hepCA.UAS has eye phenotype, non-suppressible by Mkk4Asp.UAS, Scer\GAL4GMR.PF
Scer\GAL4GMR.PF, hepCA.UAS has eye phenotype, non-suppressible by Tab2[+]/Tab2G71
Scer\GAL4GMR.PF, hepCA.UAS has eye phenotype, non-suppressible by Tak1unspecified
Scer\GAL4P2.4.Pdf, hepCA.UAS has ventral adult lateral neuron & axon phenotype, non-suppressible by Appld
Scer\GAL4sim.PS/hepCA.UAS is a suppressor of ventral midline of embryo | embryonic stage 13 phenotype of Scer\GAL4sim.PS, dlUAS.cHa
hepCA.UAS/Scer\GAL4GR1 is a suppressor of egg chamber | nutrition conditional phenotype of drprΔ5
hepCA.UAS/Scer\GAL4GR1 is a suppressor of follicle cell | nutrition conditional phenotype of drprΔ5
hepCA.UAS/Scer\GAL4hs.PB is a suppressor of embryonic dorsal epidermis | germline clone | rescuable maternal effect phenotype of Cka05836
40-hour- (but not 24-hour-) expression of hepCA.UAS under the control of Scer\GAL4rn-GAL4-5 (with tub-Gal80[ts] restricting expression to third instar larvae) in CtBP87De-10/+ background leads to occasional ectopic wings compared to controls.
The increased apoptosis at the morphogenetic furrow of the third instar larval eye disc and the decreased eye size in adults resulting from the expression of hepCA.Scer\UAS under the control of Scer\GAL4GMR.PU are significantly suppressed by the co-expression of either GlyatTH00482 or bskNIG.5680R, or by heterozygosity for Glyatc02982; the increased apoptosis around the anterior-posterior compartment boundary of the third instar larval wing disc and the highly penetrant loss of the anterior crossvein in the adult wing resulting from the expression of hepCA.Scer\UAS under the control of Scer\GAL4ptc-559.1 are also partially suppressed by the co-expression of either GlyatTH00482 or bskNIG.5680R, or by heterozygosity for Glyatc02982.
The formation of giant syncytia in the patches of dorsal larval epidermis expressing hepCA.Scer\UAS under the control of Scer\GAL4pnr-MD237 (using tub-Gal80ts to limit the expression to 16 hr-long pulse during the third instar) is not suppressed by co-expression of either Cdk1GL00262, aurBGL00202 or DarkGD12048, the number of nuclei within the syncytia is also not changed.
ben1 has no effect on the rough eye phenotype seen when hepCA.Scer\UAS is expressed under the control of Scer\GAL4sev.PU.
Loss of Uev1A, through co-expression of Uev1AGD6650, fails to suppress the small scutellum phenotype found in flies expressing hepCA.Scer\UAS under the control of Scer\GAL4pnr-MD237.
Expression of hepCA.Scer\UAS under the control of Scer\GAL4GR1 partially rescues the cell death defects seen in drprΔ5 mutant starvation-induced degenerating egg chambers. Many abnormal egg chambers are still seen but, unlike in drprΔ5 mutants alone, enlargement of the follicle cells occurs and germline engulfment takes place. Hyper-engulfment, where follicle cells engulf intact nurse cells, takes place in some egg chambers.
A Df(3L)H99 background fails to suppress the small eye phenotype in flies expressing egrScer\UAS.cIa under the control of Scer\GAL4GMR.PF.
Expression of thScer\UAS.cHa fails to suppress the small eye phenotype in flies expressing egrScer\UAS.cIa under the control of Scer\GAL4GMR.PF.
Expression of NcC318G.Scer\UAS fails to suppress the small eye phenotype in flies expressing egrScer\UAS.cIa under the control of Scer\GAL4GMR.PF.
Co-expression of parkScer\UAS.T:Hsap\MYC strongly suppresses the rough eye phenotype in flies and the increased cell death in third instar larval eye discs seen with expression of hepCA.Scer\UAS driven by Scer\GAL4sev.PU.
Mkk4G587/Mkk4G673 does not suppress the small eye phenotype seen when hepCA.Scer\UAS is expressed under the control of Scer\GAL4GMR.PF.
Co-expression of Mkk4Scer\UAS.cGa suppresses the small eye phenotype seen when hepCA.Scer\UAS is expression of Scer\GAL4GMR.PF.
Co-expression of Mkk4Asp.Scer\UAS is unable to suppress the small eye phenotype seen when hepCA.Scer\UAS is expression of Scer\GAL4GMR.PF.
Co-expression of Mkk4Mut.Scer\UAS suppresses the small eye phenotype seen when hepCA.Scer\UAS is expression of Scer\GAL4GMR.PF.
The wing defects caused by expression of hepCA.Scer\UAS under the control of Scer\GAL4vg.PU are enhanced in a flw1/Y background; the wings are much smaller and are frequently notched and blistered. The double mutant flies are only 10% viable relative to their flw1/+ ; hepCA.Scer\UAS, Scer\GAL4vg.PU control siblings.
Co-expression of bskdsRNA.Scer\UAS with hepCA.Scer\UAS in eye clones, under the control of Scer\GAL4GMR.PF results in partial suppression of the apoptotic eye phenotype observed in hepCA.Scer\UAS mutant clones.
Overexpression of hepCA.Scer\UAS in shgk03401 mutant cephalic cells (i.e. cells in the larval brain and eye-antennal discs) expressing Ras85DV12.Scer\UAS results in neither enhanced tumour growth nor metastatic behaviour.
Expression of hepCA.Scer\UAS, under the control of Scer\GAL4P2.4.Pdf, in an Appld mutant background still induces the significant axonal extension seen when the transgene is expressed in a wild-type background.
Leaky expression of hepCA.Scer\UAS, with no GAL4 driver, partially rescues the lethality and dorsal puckering phenotype of Rac1J11 Rac2Δ MtlΔ triple mutants.
The dorsal open phenotype seen in homozygous Cka05836 embryos derived from females carrying homozygous Cka05836 germ-line clones is substantially rescued by expression of hepCA.Scer\UAS under the control of Scer\GAL4hs.PB using heat shock.
The formation of giant syncytia in the patches of dorsal larval epidermis expressing hepCA.Scer\UAS under the control of Scer\GAL4pnr-MD237 (using tub-Gal80ts to limit the expression to 16 hr-long pulse during the third instar) is not suppressed by co-expression of BacA\p35Scer\UAS.cUa, the number of nuclei within the syncytia is also not changed.
Expression of Zzzz\E4orf4Scer\UAS.cPa has little effect on the reduced eclosion rates seen when hepCA.Scer\UAS is expressed under the control of Scer\GAL4GMR.PF at 18[o]C. However at 24[o]C the reduced eclosion rate is partially suppressed, with 89% of flies eclosing (compared to 0.75% when hepCA.Scer\UAS is expressed alone).
Expression of Zzzz\E4orf4Scer\UAS.cPa partially rescues the eye phenotypes seen when hepCA.Scer\UAS is expressed under the control of Scer\GAL4GMR.PF at 18[o]C. Eye size is restored to 25% and 31% of controls in females and males respectively (from 17% and 18%).
Co-expression of Zzzz\lefScer\UAS.cGa with hepCA.Scer\UAS under the control of Scer\GAL4CY2 driver almost completely suppresses the hepCA.Scer\UAS partial loss of the fifth longitudinal vein (L5) phenotype, indicating that Zzzz\lef acts in parallel to or downstream of hep.